Actualités et Activités de Aspira Women’s Health
Présence
Aspira Women’s Health est une société cotée sous le symbole boursier AWH (US).
Dirigeants
Voir l'organigramme avec ses 23 principaux dirigeants
Biographies les plus recherchées chez Aspira Women’s Health
- Sandra Milligan, Interim Chief Executive Officer
- Stefanie Cavanaugh, Independent Director
- Celeste Fralick, Director
Changements de dirigeants chez Aspira Women’s Health
- Ellen Beausang, a rejoint l'entreprise comme Director (publié le 11 février 2025).
- John Kallassy, Interim Chief Financial Officer, a quitté l'entreprise (publié le 13 janvier 2025).
- Nicole Sandford, Director, President and Chief Executive Officer, a quitté l'entreprise (publié le 16 décembre 2024).
Cliquez ici pour voir d'autres changements chez Aspira Women’s Health
Créer une alerte
pour suivre les mouvements de dirigeants chez Aspira Women’s Health.
Équipements médicaux
Aspira Women’s Health a 1 021 concurrents dont Philips (Pays—Bas), Medtronic (Irlande) et Thermo Fisher Scientific (Etats—Unis).
Actualités en fusion/acquisition en Équipements médicaux.
- RadNet has announced the acquisition of Icad (publié le 25 avril 2025).
- Patient Square Capital a acquis Patterson Cos (publié le 22 avril 2025).
- Globus Medical has announced the acquisition of Nevro (publié le 4 avril 2025).
Contacts en Équipements médicaux
Actualités
Derniers communiqués de presse par Aspira Women’s Health
- Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
- Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
- Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
- Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
- Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
- Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
- Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
- Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
- Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
- Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Aspira Women’s Health
- Aspira Women’s Health sur Wikipédia, Google News & Yahoo Finance en 1-click
- Aspira Women’s Health sur LinkedIn, Twitter & YouTube en 1-click
